Title: Jacob A. Orville: Innovator in Cardiovascular Risk Assessment
Introduction
Jacob A. Orville is an inventor based in Shaker Heights, OH (US). He currently works at Cleveland HeartLab, Inc., where he focuses on innovations related to cardiovascular health. Despite having no granted patents, his contributions to the field are significant through his latest patent applications.
Latest Patent Applications
Jacob A. Orville has submitted several patent applications aimed at improving cardiovascular risk assessment. One of his notable applications is titled "Compositions and Methods for Predicting Cardiovascular Events." This invention provides methods, systems, devices, panels, and software for determining values for two or more markers to characterize a subject's risk of developing cardiovascular disease or experiencing complications within one to three years. The markers include hs-CRP, ACR, Lp-Pla2, MPO, fibrinogen, KIF6, and F2 isoprostanes. Another application focuses on predicting peri-operative cardiovascular events associated with angioplasty, utilizing markers such as myeloperoxidase (MPO), F2-isoprostane (F2-IsoP), C-reactive protein (CRP), urinary micro-albumin (UMA), and lipoprotein-associated phospholipase A2 (Lp-PLAZ).
Conclusion
Jacob A. Orville is making strides in the field of cardiovascular health through his innovative patent applications. His work at Cleveland HeartLab, Inc. showcases his commitment to improving patient outcomes in cardiovascular disease.